The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The principal author Lopez Ramos, Roxana Patricia is a doctoral student studying an Epidemiological Research Doctorate at Universidad Peruana Cayetano Heredia under FONDECYT/CIENCIAACTIVA scholarship EF033-235-2015 and supported by training Grant D43 TW007393 awarded by the Fogarty International Center of the US National Institutes of Health.

Objective: The aim of the study was to describe the clinicopathological profile of patients diagnosed with liver, bile ducts or gallbladder cancer. Materials and methods: Between 2006 and 2017, 89 patients (57% female; mean age: 62 years-old) with these cancers were diagnosed at two national hospitals in Lima, Peru. Results: Most patients (64%) had advanced stages of disease. Anemia was more frequent in patients with bile duct and liver cancer and in advanced stages. Hypertension (HTN) was frequent among liver cancer patients (32%). The analysis by age showed that HTN was more frequent in patients over 50 years. Likewise, people under 50 years had more frequent history of previous infections (50%), Hepatitis B (HBV) being the most co on. Conclusions: This study describes the baseline clinicopathological characteristics of a malignancy poorly studied in Peru.